Data / Research funding / Psoriasis
Psoriasis: 71 NIH awards ($59.8M) to 38 organizations
71 NIH awards ($59.8M) in the NIH spending category Psoriasis, to 38 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
71 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,900,002 | March 21, 2022 | December 31, 2026 | RITCHLIN, CHRISTOPHER TREVOR | reporter.nih.gov |
| Single cell and spatial genomic analyses of specimens from patients with autoimmune diseases (Technology Core) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,700,281 | March 22, 2022 | December 31, 2026 | BRENNER, MICHAEL B. | reporter.nih.gov |
| The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,406,145 | August 8, 2025 | July 31, 2029 | FUJISAKI, JOJI | reporter.nih.gov |
| Regulatory Variants in Human Skin Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,487,678 | May 1, 2020 | May 31, 2030 | KHAVARI, PAUL | reporter.nih.gov |
| Immune Functions of Cutaneous Nociceptors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,315,978 | March 1, 2017 | May 31, 2027 | KAPLAN, DANIEL H | reporter.nih.gov |
| Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,314,029 | February 2, 2023 | January 31, 2028 | KESELOWSKY, BENJAMIN GEORGE | reporter.nih.gov |
| Biochemical and functional characterization of a novel anti-inflammatory biogenic amine | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,177,069 | July 6, 2023 | June 30, 2028 | SANTAMBROGIO, LAURA | reporter.nih.gov |
| Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,964,807 | September 1, 2023 | August 31, 2025 | CLARKE, WILLIAM R | reporter.nih.gov |
| Dysregulation of epidermal innate immune signaling as driver of Psoriatic-like arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,901,310 | September 15, 2025 | August 31, 2028 | RAZANI, BAHRAM | reporter.nih.gov |
| A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,854,342 | September 20, 2023 | August 31, 2027 | TUBAU-JUNI, NURIA | reporter.nih.gov |
| Genetic and Genomic Dissection of Psoriatic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,790,366 | September 12, 2012 | June 30, 2025 | ELDER, JAMES TILFORD | reporter.nih.gov |
| Deconstructing the molecular and cellular mechanisms of psoriatic arthritis pain by an improved animal model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,617,503 | September 1, 2025 | August 31, 2028 | CHEN, YONG | reporter.nih.gov |
| Epidermal Gene Regulation by Transcription Elongation and Termination | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,369,645 | September 11, 2020 | August 31, 2025 | BAO, XIAOMIN | reporter.nih.gov |
| Integrative and trans-ethnic study to understand psoriasis associated signals | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,084,048 | September 21, 2023 | August 31, 2028 | TSOI, LAM CHEUNG | reporter.nih.gov |
| Cellular Determinants of AH Receptor Signaling | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,049,958 | May 1, 2010 | April 30, 2029 | SUTTER, THOMAS R | reporter.nih.gov |
| Targeting TNFR2 Pathways in Psoriatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,048,432 | July 8, 2019 | December 31, 2024 | HUSNI, ELAINE | reporter.nih.gov |
| Kallikrein-PAR interactions in skin inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,042,041 | July 1, 2018 | June 30, 2025 | WARD, NICOLE LEANNE | reporter.nih.gov |
| Three-dimensional Ultrashort Echo Time Magnetic Resonance Imaging of Entheses | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,038,667 | July 1, 2019 | May 31, 2025 | CHANG, ERIC Y | reporter.nih.gov |
| Harnessing Human Dendritic Cell Subsets in Skin for the Design of Novel Immunotherapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,025,640 | July 4, 2019 | June 30, 2025 | KLECHEVSKY, EYNAV YAFIT | reporter.nih.gov |
| Restriction of psoriatic skin and joint disease by A20 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $907,333 | February 5, 2021 | November 30, 2025 | RAZANI, BAHRAM | reporter.nih.gov |
| Function of CD1a on Langerhans cells in skin inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $885,000 | January 22, 2018 | December 31, 2022 | WINAU, FLORIAN | reporter.nih.gov |
| Endovascular Health and Platelet Activity in Psoriasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $865,132 | February 15, 2021 | January 31, 2026 | GARSHICK, MICHAEL SETH | reporter.nih.gov |
| Precision Monitoring of Treatment Response in Early Psoriatic Arthritis: Integrating at-Home RNA Microsampling into Ongoing, Remote, Smart Phone-Based, Digital Data Capturing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $838,694 | June 15, 2024 | May 31, 2028 | SCHER, JOSE U. | reporter.nih.gov |
| Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $829,097 | September 19, 2018 | August 31, 2023 | VOLKMAN, BRIAN F | reporter.nih.gov |
| Remote Exposome Monitoring for Autoimmune Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $795,574 | September 18, 2023 | August 31, 2026 | LIAO, WILSON | reporter.nih.gov |
| TWEAK and Skin Inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $776,160 | July 18, 2018 | October 31, 2023 | CROFT, MICHAEL | reporter.nih.gov |
| Immunomodulatory mechanisms of E-FABP in psoriasis pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $769,040 | September 1, 2021 | August 31, 2024 | LI, BING | reporter.nih.gov |
| Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $767,680 | August 1, 2021 | July 31, 2026 | WEBER, BRITTANY NICOLE | reporter.nih.gov |
| Immune cell contributions to inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $735,460 | April 10, 2025 | March 31, 2030 | WARD, NICOLE LEANNE | reporter.nih.gov |
| Mechanisms of Glucose Dependence in Proliferating Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $698,544 | April 1, 2018 | March 31, 2024 | WANG, RICHARD C | reporter.nih.gov |
| Linking Disease Mechanisms and Outcomes in Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $687,452 | July 6, 2020 | May 31, 2030 | KAHLENBERG, JOANNE MICHELLE | reporter.nih.gov |
| A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $677,429 | August 18, 2022 | July 31, 2027 | KIM, JAEHWAN | reporter.nih.gov |
| Impact of dietary lipid components on phototherapy used to treat inflammatory skin conditions | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $673,729 | April 10, 2025 | March 31, 2030 | SCHOPFER, FRANCISCO JOSE | reporter.nih.gov |
| Cellular and Molecular Mechanisms of IL-17A in the Pathogenesis of Psoriatic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $664,933 | May 15, 2025 | March 31, 2026 | ADAMOPOULOS, IANNIS ELIAS | reporter.nih.gov |
| Drug Screening with a Biofrabricated 3-D Immunocompetent Skin Model for Drug Discovery in Psoriatic Disease | NIH | National Center for Advancing Translational Sciences | 2021 | $641,186 | August 28, 2020 | July 31, 2023 | CHRISTIANO, ANGELA M | reporter.nih.gov |
| Defining and treating genetic abnormalities in psoriasis/atopic dermatitis-overlap dermatoses | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $628,968 | June 20, 2025 | April 30, 2030 | CHO, RAYMOND JAIHYUN | reporter.nih.gov |
| Linkage Analysis of Familial Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $532,229 | March 10, 1994 | March 31, 2022 | ELDER, JAMES TILFORD | reporter.nih.gov |
| Role of IFN kappa in psoriasis-mediated diabetes development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $497,998 | August 10, 2022 | June 30, 2027 | WOLF-FORTUNE, SONYA J | reporter.nih.gov |
| Association of Phenotypes and Genotype with Treatment Response in Psoriatic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $490,552 | July 14, 2023 | June 30, 2028 | KARMACHARYA, PARAS | reporter.nih.gov |
| Dissecting interplay between electrophilic stress and IkBz-driven inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $431,376 | February 1, 2022 | January 31, 2025 | BAMBOUSKOVA, MONIKA | reporter.nih.gov |
| The role of CXCL10 expressing B cells in skin inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $429,000 | June 6, 2024 | April 30, 2026 | DEBES, GUDRUN PHILOMENA | reporter.nih.gov |
| microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $403,508 | July 1, 2021 | June 30, 2024 | BENDER, JEFFREY R. | reporter.nih.gov |
| Role of healthy skin molecular phenotype in the switch to specific skin diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $399,812 | September 23, 2022 | August 31, 2025 | BUDUNOVA, IRINA | reporter.nih.gov |
| A mechanistic investigation of SerpinB3 and its role in psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $390,913 | July 2, 2025 | May 31, 2030 | YARON, JORDAN ROBIN | reporter.nih.gov |
| STAT2 Signaling in the Pathogenesis of Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $381,827 | July 1, 2021 | June 30, 2023 | GAMERO, ANA M | reporter.nih.gov |
| P2X7 Receptor Splice Variants in Psoriasis Pathophysiology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $379,278 | May 1, 2021 | April 30, 2023 | MATHERS, ALICIA R | reporter.nih.gov |
| Cell-penetrating botulinum proteases as topical therapeutics | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $359,216 | August 20, 2024 | July 31, 2027 | JIN, RONGSHENG | reporter.nih.gov |
| Clinical and neuroimaging determinants of persistent joint pain in psoriatic arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $351,648 | April 1, 2024 | March 31, 2028 | HABERMAN, REBECCA | reporter.nih.gov |
| Assessment of Treatment Satisfaction in Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $348,740 | September 20, 2023 | February 28, 2027 | ARMSTRONG, APRIL W | reporter.nih.gov |
| Longitudinal relationships among sleep health, systemic inflammation, and disease activity in psoriatic arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $347,760 | August 13, 2024 | July 31, 2029 | PEREZ CHADA, LOURDES | reporter.nih.gov |
| Down syndrome and Psoriasis: An Investigation of Cardiometabolic Risk | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $310,000 | May 1, 2024 | April 30, 2026 | RORK, JILLIAN | reporter.nih.gov |
| Respiratory infections and vaccination behaviors in patients with chronic inflammatory skin diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $305,095 | July 1, 2019 | June 30, 2024 | NOE, MEGAN H | reporter.nih.gov |
| Deciphering the endotypes and signature of non-response in a humanized murine model of PsA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $300,000 | September 5, 2025 | August 31, 2026 | GARCIA-HERNANDEZ, MARIA DE LA LUZ | reporter.nih.gov |
| Development of Novel Topical Therapeutics for Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $295,924 | September 5, 2023 | August 31, 2025 | TUBAU JUNI, NURIA | reporter.nih.gov |
| A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $295,294 | September 20, 2023 | March 31, 2025 | TUBAU JUNI, NURIA | reporter.nih.gov |
| Kallikrein-PAR interactions in skin inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $255,432 | July 1, 2018 | January 31, 2022 | WARD, NICOLE LEANNE | reporter.nih.gov |
| Characterization of Spinal Pathology in Axial Psoriatic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $239,488 | December 5, 2024 | November 30, 2027 | CHAUDHARI, ABHIJIT J | reporter.nih.gov |
| The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $216,272 | August 1, 2023 | July 31, 2025 | MOGILENKO, DENIS | reporter.nih.gov |
| Assessment of Treatment Satisfaction in Psoriasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $200,292 | May 1, 2023 | July 14, 2023 | ARMSTRONG, APRIL W | reporter.nih.gov |
| Metabolomics and transcriptomics analyses of cell-specific regulation of fatty acid synthesis and metabolic reprogramming in skin inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $195,000 | June 17, 2024 | April 30, 2027 | KANG, YOUNG JUN | reporter.nih.gov |
| Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasis | NIH | National Heart, Lung, and Blood Institute | 2025 | $194,400 | September 1, 2025 | August 31, 2027 | WEBER, BRITTANY NICOLE | reporter.nih.gov |
| Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $189,495 | April 20, 2017 | March 31, 2024 | YAN, JUN | reporter.nih.gov |
| Role of IFN kappa in psoriasis-mediated diabetes development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $180,000 | August 10, 2022 | June 30, 2024 | WOLF-FORTUNE, SONYA J | reporter.nih.gov |
| The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $173,067 | September 1, 2022 | July 31, 2023 | MOGILENKO, DENIS | reporter.nih.gov |
| Predicting poor response to therapy and developing interventions to improve outcomes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $164,830 | September 1, 2025 | August 31, 2030 | OGDIE, ALEXIS R. | reporter.nih.gov |
| Role of antiviral signaling in psoriatic pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $161,500 | April 1, 2023 | March 31, 2025 | RAZANI, BAHRAM | reporter.nih.gov |
| Targeting keratinocyte cholesterol metabolism to reveal novel mechanisms for treating inflammatory skin disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $139,911 | September 1, 2022 | August 31, 2025 | TRUJILLO, JACQUELYN | reporter.nih.gov |
| Regulation of epidermal homeostasis by centrosomal proteins | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $129,035 | September 26, 2025 | August 31, 2030 | YOKOYAMA, CHRISTINE CHIEKO | reporter.nih.gov |
| Integrative Biology Approach to Identify and Characterize Roles of lncRNAs Associated with Psoriasis Pathology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $98,982 | September 1, 2017 | August 31, 2022 | TSOI, LAM CHEUNG | reporter.nih.gov |
| Continuous monitoring of epidermal inflammatory response to mechanical strain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $49,538 | September 1, 2025 | August 31, 2028 | SEDLACK, ANDREW JACOB HERSE | reporter.nih.gov |
| Decoding the mechanism of inflammatory memory in human epithelia | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $48,974 | June 1, 2025 | May 31, 2028 | DACCACHE, JOSEPH | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 39 | $20,543,367 | 0 | $0 |
| 2024 | 27 | $9,692,521 | 0 | $0 |
| 2023 | 30 | $12,018,707 | 0 | $0 |
| 2022 | 27 | $8,507,222 | 0 | $0 |
| 2021 | 27 | $9,053,921 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.